Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 9/20 | 0.58 |
| ▸ | CCND1 | P24385 | 9/20 | 0.58 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.53 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.53 |
| ▸ | CDK1 | P06493 | 1/20 | 0.53 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.53 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.53 |
| ▸ | CDK2 | P24941 | 1/20 | 0.53 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.53 |
| ▸ | FEN1 | P39748 | 1/20 | 0.40 |
| ▸ | CSF1R | P07333 | 2/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.38 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.38 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.38 |
| ▸ | LTK | P29376 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24408621 | 0.84 | CDK4 (0.43) | CDK4CCND1CCNB2CCNE2CDK1 | |
| SCHEMBL25705540 | 0.83 | CDK4 (0.58) | CDK4CCND1CCNB2CCNE2CDK1 | |
| SCHEMBL29143350 | 0.78 | CDK4 (0.65) | CDK4CCND1CCNB2CCNE2CDK1 | |
| SCHEMBL30715243 | 0.78 | CDK4 (0.65) | CDK4CCND1CCNB2CCNE2CDK1 | |
| SCHEMBL17381082 | 0.78 | GABRP (0.44) | CDK4CCND1CDK5MEN1MAPT | |
| SCHEMBL19784899 | 0.77 | KIF11 (0.51) | CDK4CCND1CCNB2CCNE2CDK1 | |
| SCHEMBL29462014 | 0.76 | CYP3A4 (0.45) | CSF1RCLK4LIMK1MEN1PDGFRB | |
| SCHEMBL997084 | 0.76 | CYP3A4 (0.45) | CSF1RCLK4LIMK1MEN1PDGFRB | |
| SCHEMBL25680066 | 0.76 | ALDH1A1 (0.45) | CDK5MEN1MAPTKMT2ADYRK1A | |
| SCHEMBL24036636 | 0.76 | CDK4 (0.74) | CDK4CCND1CCNB2CCNE2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210000-A1 | COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE | KYULUX, INC. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-11367839-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-06-21 | — | — | US | disclosed |
| WO-2019172623-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2019-09-12 | — | — | WO | disclosed |
| WO-2019160335-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2019-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230210000-A1 | COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE | DRD1, DRD2, DRD3 | CDK4 47/4885CCND1 30/4885CCNB2 439/4885 |
| US-11367839-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | ORAI2, KCNJ2, OR10J3 | CDK4 2368/4885CCND1 1522/4885CCNB2 1311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.